Literature DB >> 16554453

Patterns of drug utilization in a neonatal intensive care unit.

Indulekha Warrier1, Wei Du, Girija Natarajan, Vali Salari, Jacob Aranda.   

Abstract

The objective of this study was to determine drug use in newborns at an inborn tertiary care neonatal intensive care unit, serving a predominantly African American population, to identify educational/research priorities in neonatal drug therapy. Data on demographics and exposure rates to all drugs from 6839 neonates born between January 1997 and June 2004 were analyzed. Number of drugs used was correlated with race, gender, gestational age, birthweight, and survival status. The contribution of these factors to mean drug use was predicted by multivariate regression analysis. In this population of 80% African Americans, mean drug use was 3.6/infant, with the highest use in the 24- to 27-week gestational age group (11.7/infant). Ampicillin and cefotaxime had the highest exposure rates. Premature infants had high use of surfactant, pressor agents, and diuretics. Caucasians, males, gestational age<28 weeks, and birthweight<1000 g were the risk factors for higher drug exposure. Future research/education must emphasize these therapeutic areas with priority assigned to low-birthweight infants.

Entities:  

Mesh:

Year:  2006        PMID: 16554453     DOI: 10.1177/0091270005285456

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  22 in total

1.  Drug utilisation profile in the neonatal unit of a university hospital: a prospective observational study in Brazil.

Authors:  Adriana Cristina de Souza Gonçalves; Adriano Max Moreira Reis; Ana Carolina Marçal Gusmão; Maria Cândida Ferrarez Bouzada
Journal:  Int J Clin Pharm       Date:  2015-04-02

Review 2.  Clinical pharmacokinetics of penicillins in the neonate: a review of the literature.

Authors:  G M Pacifici; J Labatia; H Mulla; I Choonara
Journal:  Eur J Clin Pharmacol       Date:  2008-09-23       Impact factor: 2.953

3.  Medications for premature neonates: healthcare considerations.

Authors:  Hervé Walti
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

Review 4.  Collaboration in Regulatory Science to Facilitate Therapeutic Development for Neonates.

Authors:  Susan K McCune; Yeruk Ager Mulugeta; Gerri R Baer
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 5.  Two decades of off-label prescribing in children: a literature review.

Authors:  Shamala Balan; Mohamed Azmi Ahmad Hassali; Vivienne S L Mak
Journal:  World J Pediatr       Date:  2018-09-14       Impact factor: 2.764

6.  Antimicrobial Utilization Pattern in Pediatric Patients in Tertiary Care Hospital, Eastern Ethiopia: The Need for Antimicrobial Stewardship.

Authors:  Samuel Girma; Mekonnen Sisay; Getnet Mengistu; Firehiwot Amare; Dumessa Edessa
Journal:  Hosp Pharm       Date:  2017-10-31

7.  Effects of gender on the health and development of medically at-risk infants.

Authors:  June Cho; Diane Holditch-Davis; Margaret S Miles
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2010 Sep-Oct

8.  Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study.

Authors:  Carol J Blaisdell; James Troendle; Anne Zajicek
Journal:  J Pediatr       Date:  2018-03-26       Impact factor: 4.406

9.  Drug utilisation pattern and off-label use of medicines in Estonian neonatal units.

Authors:  Jana Lass; Ruth Käär; Kaarin Jõgi; Heili Varendi; Tuuli Metsvaht; Irja Lutsar
Journal:  Eur J Clin Pharmacol       Date:  2011-06-11       Impact factor: 2.953

10.  Drug utilisation on a preterm and neonatal intensive care unit in Germany: a prospective, cohort-based analysis.

Authors:  Antje Neubert; Kristin Lukas; Thomas Leis; Harald Dormann; Kay Brune; Wolfgang Rascher
Journal:  Eur J Clin Pharmacol       Date:  2009-09-16       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.